Daily Memo: Vaccine Trial Successes Shift Recovery Timeline Forward

generic planes parked
Credit: ACI World
The airline industry is bracing for a long winter, but there is light at the end of the tunnel. Airline and travel stocks were boosted recently after two COVID-19 vaccines under development—one from Pfizer and BioNTech, and the other from Moderna—logged initial efficacy rates exceeding 90% in late...
Ben Goldstein

Based in Boston, Ben covers advanced air mobility and is managing editor of Aviation Week Network’s AAM Report.

Subscription Required

 

Daily Memo: Vaccine Trial Successes Shift Recovery Timeline Forward is published in Aviation Daily, an Aviation Week Intelligence Network (AWIN) Market Briefing and is included with your AWIN membership.

Already a member of AWIN or subscribe to Aviation Daily through your company? Login with your existing email and password

Not a member?  Learn how to access the market intelligence and data you need to stay abreast of what's happening in the air transport community.